Fny Investment Advisers, LLC Sarepta Therapeutics, Inc. Transaction History

Fny Investment Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	BUY	$67.31 - $124.76 $33,655 - $62,380	500 New	500 $48,000
Q4 2019 Jan 10, 2020	SELL	$76.53 - $135.58 $157,269 - $278,616	-2,055 Closed	0 $0
Q3 2019 Oct 25, 2019	SELL	$72.81 - $156.91 $125,451 - $270,355	-1,723 Reduced 45.61%	2,055 $154,000
Q2 2019 Jul 24, 2019	BUY	$112.21 - $151.95 $87,299 - $118,217	778 Added 25.93%	3,778 $574,000
Q1 2019 Apr 17, 2019	BUY	$106.67 - $151.68 $266,675 - $379,200	2,500 Added 500.0%	3,000 $357,000
Q4 2018 Jan 22, 2019	SELL	$97.32 - $148.76 $145,980 - $223,140	-1,500 Reduced 75.0%	500 $54,000
Q3 2018 Oct 29, 2018	BUY	$115.31 - $161.51 $227,045 - $318,013	1,969 Added 6351.61%	2,000 $323,000
Q2 2018 Jul 18, 2018	BUY	$71.74 - $153.69 $2,223 - $4,764	31 New	31 $4,000

524

85.2M

1.74M

1.39M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.87B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.